Home

Dag Hiel vereist kevin harrington icr Glimlach Messing Occlusie

The ICR on Twitter: "Professors Kevin Harrington and Alan Melcher (ICR +  @royalmarsdenNHS) featured earlier in a @BBCr4today segment on  #immunotherapy. In the UK you can still listen to today's live program
The ICR on Twitter: "Professors Kevin Harrington and Alan Melcher (ICR + @royalmarsdenNHS) featured earlier in a @BBCr4today segment on #immunotherapy. In the UK you can still listen to today's live program

Higher Scientific Officer - Targeted Therapy Team, Prof Kevin Harrington  (ID496) at The Institute of Cancer Research
Higher Scientific Officer - Targeted Therapy Team, Prof Kevin Harrington (ID496) at The Institute of Cancer Research

Cancer: Scientists aim to double survival within a decade | The Independent
Cancer: Scientists aim to double survival within a decade | The Independent

Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The  Institute of Cancer Research, London
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London

Histological and functional studies of isolated arteries containing  contrast agents exposed to high intensity focused ultrasoun
Histological and functional studies of isolated arteries containing contrast agents exposed to high intensity focused ultrasoun

Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London

Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London

High-tech radiotherapy, drug combinations and immunotherapy showcased as  future of cancer treatment - The Institute of Cancer Research, London
High-tech radiotherapy, drug combinations and immunotherapy showcased as future of cancer treatment - The Institute of Cancer Research, London

Professor Kevin Harrington | The Royal Marsden
Professor Kevin Harrington | The Royal Marsden

The Institute of Cancer Research - Professor Kevin Harrington (ICR + Royal  Marsden NHS Foundation Trust) responds to today's news of the 2018 Nobel  Prize for Physiology or Medicine being awarded to
The Institute of Cancer Research - Professor Kevin Harrington (ICR + Royal Marsden NHS Foundation Trust) responds to today's news of the 2018 Nobel Prize for Physiology or Medicine being awarded to

ICR calls for improved biomarker cancer tests to help personalise treatment  - PMLiVE
ICR calls for improved biomarker cancer tests to help personalise treatment - PMLiVE

Statement about NICE decision on T-VEC for treating inoperable metastatic  melanoma | The Royal Marsden
Statement about NICE decision on T-VEC for treating inoperable metastatic melanoma | The Royal Marsden

The ICR on Twitter: "Professor Kevin Harrington specialises in  #HeadAndNeckCancer. He and his team study the use of biologically targeted  agents, in combination with treatments such as #Radiotherapy and  #Chemotherapy, to target #
The ICR on Twitter: "Professor Kevin Harrington specialises in #HeadAndNeckCancer. He and his team study the use of biologically targeted agents, in combination with treatments such as #Radiotherapy and #Chemotherapy, to target #

Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London

Royal Marsden researchers named among world's most influential scientists |  The Royal Marsden
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden

Using Viruses to Treat Cancer | Prof Kevin Harrington | #SCIPEL 2015 | SCI  - YouTube
Using Viruses to Treat Cancer | Prof Kevin Harrington | #SCIPEL 2015 | SCI - YouTube

ICR Postdoc Association (PDA) (@Postdocs_ICR) / Twitter
ICR Postdoc Association (PDA) (@Postdocs_ICR) / Twitter

Using imaging to predict and improve responses to immunotherapy - Oracle  Cancer Trust
Using imaging to predict and improve responses to immunotherapy - Oracle Cancer Trust

Radiotherapy supercharges cancer-targeting viruses to treat deadly skin  cancer - The Institute of Cancer Research, London
Radiotherapy supercharges cancer-targeting viruses to treat deadly skin cancer - The Institute of Cancer Research, London

Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London

Scientific Lecture | Kevin Harrington | FRONTAL
Scientific Lecture | Kevin Harrington | FRONTAL

The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the  @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR  #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter
The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter

Tumour assassination – using smart targeted treatments to enhance  anti-cancer radiation responses - The Institute of Cancer Research, London
Tumour assassination – using smart targeted treatments to enhance anti-cancer radiation responses - The Institute of Cancer Research, London

ICR researchers named among world's most influential scientists - The  Institute of Cancer Research, London
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London

Oracle Research Event 2019 Kevin Harrington: Radiotherapy - YouTube
Oracle Research Event 2019 Kevin Harrington: Radiotherapy - YouTube